The 2020 Presidential Election: Implications for Women’s Health October 15, 2020 Issue Brief This brief and side-by-side tables reviews the key health issues that are likely to have a direct impact on women’s health as well as their access to coverage and care, and summarizes the presidential candidates’ stated positions and records on these issues.
Intrauterine Devices (IUDs): Access for Women in the U.S. September 9, 2020 Fact Sheet Intrauterine devices (IUDs), along with implants, are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years. This fact sheet reviews the various IUDs approved by the FDA; awareness, use, and availability of IUDs; and key issues in insurance coverage and financing of IUDs in the United States.
Contraception X Article: Out-of-Pocket Spending for Oral Contraceptives Among Women with Private Insurance Coverage After the Affordable Care Act August 21, 2020 Issue Brief In an article for Contraception X, KFF’s Brittni Frederiksen, Matthew Rae, and Alina Salganicoff examine large employer plans to identify which types and brands of oral contraceptive pills have the largest shares of oral contraceptive users with out-of-pocket spending and which oral contraceptives have the highest average annual out-of-pocket costs after the ACA covered contraception under it’s preventive services provisions.
How Publicly-Funded Family Planning Providers are Adapting in the COVID-19 Pandemic May 5, 2020 Issue Brief This issue brief describes how publicly-funded family planning providers are adapting in the COVID-19 pandemic and strategies they have implemented to continue providing quality family planning services while in-person visits are limited.
Round 3: Legal Challenges to Contraceptive Coverage at SCOTUS May 4, 2020 Issue Brief This brief explains how the new regulations issued by the Trump Administration would change the contraceptive coverage requirement for employers and affect women’s coverage, the legal positions for challenging and defending these regulations, the potential rulings, and the broader ramifications.
This Week in Coronavirus: April 17 to April 24 April 24, 2020 Blog Every Friday we’ll recap our new coronavirus policy analysis, polling, and updates from the past week.
A Look at Online Platforms for Contraceptive and STI Services during the COVID-19 Pandemic April 23, 2020 Issue Brief There has been a proliferation of online services in recent years that seek to offer individuals that cannot make it to a clinic or do not have an established source of care access to some contraceptive methods and STI testing through a telemedicine platform, usually a website or a smartphone application. This data note provides an overview of options available for the online management of sexual and reproductive health services during the coronavirus pandemic and discusses the opportunities and limitations of these platforms in terms of availability and cost.
Online Contraceptive and STI Services During COVID-19: What are the options? April 23, 2020 News Release A new KFF issue brief provides an overview of online options for contraceptive and STI services during the COVID-19 pandemic. This resource also includes an interactive table that shows which platforms are available in each state and which accept private insurance or Medicaid.
Sexually Transmitted Infections (STIs): An Overview, Payment, and Coverage February 18, 2020 Fact Sheet More people have health insurance than ever before under the Affordable Care Act (ACA), which emphasizes preventive care, including no-cost HIV and STI counseling and screening for recommended populations. This fact sheet examines trends and disparities in STI prevalence, reviews the STI screening and preventive care coverage policies for private insurance and public programs, and discusses coverage gaps and confidentiality concerns in the provision of these services.
Use of Telemedicine for Sexual and Reproductive Health is Low – Despite Potential to Improve Access to Care November 22, 2019 News Release New KFF analysis outlines the growing use of telemedicine for contraception, abortion and STI care, including a discussion of insurance coverage of telemedicine services, the financial implications for providers and patients, and its potential to improve access to reproductive health care across the United States.